![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PFIZER WINS VIAGRA TRADEMARK CASE IN CHINA
PFIZER WINS VIAGRA TRADEMARK CASE IN CHINA
A Beijing court has ordered the three Chinese drugmakers to pay a $38,000 fine, apologize publicly and stop making counterfeit versions of Pfizer's blockbuster drug Viagra, a Pfizer spokesman said.
Pfizer representative Bryant Haskins said the company won a trademark case in China blocking drugmakers from making pharmaceutical products that look like the blue, diamond-shaped impotence drug.
"They were convicted of reproducing the diamond-shaped Viagra look. They had to pull it off the market," Haskins said. The drug manufacturers must print a public apology in a Chinese newspaper, he said.
The fake product did not contain the patented active ingredient in Viagra and therefore it is not considered to be a generic equivalent, Haskins said. He said the ruling demonstrated the seriousness with which the Chinese government considers the rights of companies with a patented product.
"We believe that court decision is a strong indication that the Chinese government is moving in the right direction to protect intellectual property rights for innovators making or selling products in China," Haskins said.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
18Jul
-
21Oct